Analyze Diet
Influenza and other respiratory viruses2010; 4(6); 339-344; doi: 10.1111/j.1750-2659.2010.00176.x

Equine influenza – surveillance and control.

Abstract: Equine influenza virus (EIV) is considered the most important respiratory virus of horses because it is highly contagious and has the potential to disrupt major equestrian events. Equine influenza (EI) can be controlled by vaccination but it has been demonstrated repeatedly in the field that antigenic drift impacts on vaccine efficacy. EI surveillance maintains awareness of emergence and international spread of antigenic variants. It not only serves as an early warning system for horse owners, trainers and veterinary clinicians but is fundamental to influenza control programmes based on vaccination. Data on outbreaks of EI and strain characterisation is reviewed annually by an Expert Surveillance Panel (ESP) including representatives from OIE and WHO. This panel makes recommendations on the need to update vaccines based on analysis of evidence of disease in well vaccinated horses, antigenic changes, genetic changes and when possible, experimental challenge data. However, the disparity in the level of surveillance and virus collection in different countries results in potentially biased information about the relative prevalence of different viruses. There is a need for increased surveillance on a global level and a greater awareness of the benefits of updating the vaccines. The vaccine companies have traditionally been slow to respond to the ESP recommendations. Veterinary clinicians have a major role to play in purchasing vaccines with epidemiologically relevant strains and promoting their benefits to their clients.
Publication Date: 2010-10-21 PubMed ID: 20958927PubMed Central: PMC4634605DOI: 10.1111/j.1750-2659.2010.00176.xGoogle Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
  • Journal Article
  • Review

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

This research article discusses the constant threat posed by Equine Influenza Virus (EIV) to horses and the mechanisms in place for its surveillance and control. It highlights the role of vaccines in controlling EIV and the challenges posed by antigenic drift which affects the efficacy of such vaccines. The article emphasizes the need for a more globally coordinated approach for surveillance and data collection, and stresses the need for prompt action by vaccine companies on expert recommendations for vaccine updates.

Understanding Equine Influenza

  • The research paper revolves around Equine Influenza Virus (EIV), a highly contagious respiratory virus that significantly affects horses. Despite being managed through vaccination, the virus subtly changes its structures – a phenomenon known as antigenic drift – which reduces the effectiveness of the vaccines.
  • Regular monitoring or surveillance is critical to track the emergence of new virus variants and their global spread. The surveillance system aids in providing early warnings to the owners and veterinary doctors about potential threats. It also forms the backbone of influenza control programs centered around vaccination.

Role of the Expert Surveillance Panel

  • A panel of experts, including representatives from The World Organisation for Animal Health (OIE) and World Health Organization (WHO), review data on EIV outbreaks and the characteristics of the causing strains.
  • Based on the evidence gathered about the disease in vaccinated horses, antigenic and genetic changes, and experimental challenge data (if available), the panel provides recommendations on changes needed in vaccine composition.

Disparities in Surveillance and Need for Global Cooperation

  • The research paper underscores that the level of surveillance and virus information collection varies greatly among countries, leading to biased data about the relative prevalence of different viruses.
  • It also emphasizes the need for increased global cooperation in data collection and surveillance, and greater accountability in updating vaccines for significant benefits.

Responsibility of Vaccine Companies and Veterinarians

  • The paper outlines that vaccine manufacturing companies have often been slow in responding to the recommendations made by the Expert Surveillance Panel.
  • It suggests that veterinarians have a crucial role in adopting vaccines that have strains relevant to the current epidemiological situation and communicating their benefits to their clients to control the spread of EIV more effectively.

Cite This Article

APA
Cullinane A, Elton D, Mumford J. (2010). Equine influenza – surveillance and control. Influenza Other Respir Viruses, 4(6), 339-344. https://doi.org/10.1111/j.1750-2659.2010.00176.x

Publication

ISSN: 1750-2659
NlmUniqueID: 101304007
Country: England
Language: English
Volume: 4
Issue: 6
Pages: 339-344

Researcher Affiliations

Cullinane, Ann
  • Virology Unit, The Irish Equine Centre, Johnstown, Naas, Co. Kildare, Ireland. acullinane@equine-centre.ie
Elton, Debra
    Mumford, Jenny

      MeSH Terms

      • Animals
      • Disease Outbreaks
      • Horse Diseases / epidemiology
      • Horse Diseases / prevention & control
      • Horse Diseases / virology
      • Horses
      • Influenza Vaccines / administration & dosage
      • Influenza Vaccines / immunology
      • Orthomyxoviridae / classification
      • Orthomyxoviridae / immunology
      • Orthomyxoviridae / isolation & purification
      • Orthomyxoviridae Infections / epidemiology
      • Orthomyxoviridae Infections / prevention & control
      • Orthomyxoviridae Infections / veterinary
      • Orthomyxoviridae Infections / virology
      • Sentinel Surveillance / veterinary

      References

      This article includes 37 references
      1. van Maanen C, Cullinane A. Equine influenza virus infections: an update.. Vet Q 2002 Jun;24(2):79-94.
        pubmed: 12095083doi: 10.1080/01652176.2002.9695127google scholar: lookup
      2. Glass K, Wood JL, Mumford JA, Jesset D, Grenfell BT. Modelling equine influenza 1: a stochastic model of within-yard epidemics.. Epidemiol Infect 2002 Jun;128(3):491-502.
        pmc: PMC2869847pubmed: 12113495doi: 10.1017/s0950268802006829google scholar: lookup
      3. Timoney PJ. Factors influencing the international spread of equine diseases.. Vet Clin North Am Equine Pract 2000 Dec;16(3):537-51, x.
        pubmed: 11219348doi: 10.1016/s0749-0739(17)30094-9google scholar: lookup
      4. Wood JLN. Equine Influenza: A Review of the History and Epidemiology and a Description of Recent Outbreak. MSc Dissertation, London School of Hygiene and Tropical Medicine, University of London, London. 1991.
      5. Garner MG, Cowled B, East IJ, Moloney BJ, Kung NY. Evaluating the effectiveness of early vaccination in the control and eradication of equine influenza--a modelling approach.. Prev Vet Med 2011 Apr 1;99(1):15-27.
      6. Yamanaka T, Niwa H, Tsujimura K, Kondo T, Matsumura T. Epidemic of equine influenza among vaccinated racehorses in Japan in 2007.. J Vet Med Sci 2008 Jun;70(6):623-5.
        pubmed: 18628606doi: 10.1292/jvms.70.623google scholar: lookup
      7. Mumford JA, Wood J. Establishing an acceptability threshold for equine influenza vaccines.. Dev Biol Stand 1992;79:137-46.
        pubmed: 1286748
      8. Newton JR, Townsend HG, Wood JL, Sinclair R, Hannant D, Mumford JA. Immunity to equine influenza: relationship of vaccine-induced antibody in young Thoroughbred racehorses to protection against field infection with influenza A/equine-2 viruses (H3N8).. Equine Vet J 2000 Jan;32(1):65-74.
        pubmed: 10661388doi: 10.2746/042516400777612116google scholar: lookup
      9. Mumford JA. Biology, epidemiology and vaccinology of equine influenza. Quality control of equine influenza vaccines, Proceedings of the International Symposium organised by the European Directorate for the Quality of Medicines (EDQM) Budapest, 10–11 December 2001: 7–12.
      10. Paillot R, Hannant D, Kydd JH, Daly JM. Vaccination against equine influenza: quid novi?. Vaccine 2006 May 8;24(19):4047-61.
        pubmed: 16545507doi: 10.1016/j.vaccine.2006.02.030google scholar: lookup
      11. Townsend HG, Penner SJ, Watts TC, Cook A, Bogdan J, Haines DM, Griffin S, Chambers T, Holland RE, Whitaker-Dowling P, Youngner JS, Sebring RW. Efficacy of a cold-adapted, intranasal, equine influenza vaccine: challenge trials.. Equine Vet J 2001 Nov;33(7):637-43.
        pubmed: 11770983doi: 10.2746/042516401776249354google scholar: lookup
      12. Edlund Toulemonde C, Daly J, Sindle T, Guigal PM, Audonnet JC, Minke JM. Efficacy of a recombinant equine influenza vaccine against challenge with an American lineage H3N8 influenza virus responsible for the 2003 outbreak in the United Kingdom.. Vet Rec 2005 Mar 19;156(12):367-71.
        pubmed: 15816180doi: 10.1136/vr.156.12.367google scholar: lookup
      13. Quinlivan M, Zamarin D, García-Sastre A, Cullinane A, Chambers T, Palese P. Attenuation of equine influenza viruses through truncations of the NS1 protein.. J Virol 2005 Jul;79(13):8431-9.
      14. Chambers TM, Quinlivan M, Sturgill T, Cullinane A, Horohov DW, Zamarin D, Arkins S, García-Sastre A, Palese P. Influenza A viruses with truncated NS1 as modified live virus vaccines: pilot studies of safety and efficacy in horses.. Equine Vet J 2009 Jan;41(1):87-92.
        pmc: PMC2878972pubmed: 19301588doi: 10.2746/042516408x371937google scholar: lookup
      15. Webster RG. Are equine 1 influenza viruses still present in horses?. Equine Vet J 1993 Nov;25(6):537-8.
      16. Livesay GJ, O'Neill T, Hannant D, Yadav MP, Mumford JA. The outbreak of equine influenza (H3N8) in the United Kingdom in 1989: diagnostic use of an antigen capture ELISA.. Vet Rec 1993 Nov 20;133(21):515-9.
        pubmed: 8310627doi: 10.1136/vr.133.21.515google scholar: lookup
      17. Newton JR, Daly JM, Spencer L, Mumford JA. Description of the outbreak of equine influenza (H3N8) in the United Kingdom in 2003, during which recently vaccinated horses in Newmarket developed respiratory disease.. Vet Rec 2006 Feb 11;158(6):185-92.
        pubmed: 16474051doi: 10.1136/vr.158.6.185google scholar: lookup
      18. Nelly M. Characterisation of Equine Influenza Virus Isolates from the 1989 and 1992 Influenza Outbreaks in Ireland by Nucleotide Sequence Determination of the Haemaglutinin Molecule. MSc Dissertation, University College Dublin, Dublin, 1996.
      19. Daly JM, Yates RJ, Browse G, Swann Z, Newton JR, Jessett D, Davis-Poynter N, Mumford JA. Comparison of hamster and pony challenge models for evaluation of effect of antigenic drift on cross protection afforded by equine influenza vaccines.. Equine Vet J 2003 Jul;35(5):458-62.
        pubmed: 12875323doi: 10.2746/042516403775600433google scholar: lookup
      20. Newton JR, Verheyen K, Wood JL, Yates PJ, Mumford JA. Equine influenza in the United Kingdom in 1998.. Vet Rec 1999 Oct 16;145(16):449-52.
        pubmed: 10576277doi: 10.1136/vr.145.16.449google scholar: lookup
      21. Park AW, Wood JL, Daly JM, Newton JR, Glass K, Henley W, Mumford JA, Grenfell BT. The effects of strain heterology on the epidemiology of equine influenza in a vaccinated population.. Proc Biol Sci 2004 Aug 7;271(1548):1547-55.
        pmc: PMC1691760pubmed: 15306299doi: 10.1098/rspb.2004.2766google scholar: lookup
      22. King E, Macdonald D. Report of the Board of Inquiry appointed by the Board of the National Horseracing Authority to conduct enquiry into the causes of the equine influenza which started in the Western Cape in early December 2003 and spread to the Eastern Cape and Gauteng. Aust Equine Vet 2004; 23:139–142.
      23. Powell DG, Watkins KL, Li PH, Shortridge KF. Outbreak of equine influenza among horses in Hong Kong during 1992.. Vet Rec 1995 May 27;136(21):531-6.
        pubmed: 7660556doi: 10.1136/vr.136.21.531google scholar: lookup
      24. Guo Y, Wang M, Kawaoka Y, Gorman O, Ito T, Saito T, Webster RG. Characterization of a new avian-like influenza A virus from horses in China.. Virology 1992 May;188(1):245-55.
        pubmed: 1314452doi: 10.1016/0042-6822(92)90754-dgoogle scholar: lookup
      25. Abdel-Moneim AS, Abdel-Ghany AE, Shany SA. Isolation and characterization of highly pathogenic avian influenza virus subtype H5N1 from donkeys.. J Biomed Sci 2010 Apr 14;17(1):25.
        pmc: PMC2867947pubmed: 20398268doi: 10.1186/1423-0127-17-25google scholar: lookup
      26. Crawford PC, Dubovi EJ, Castleman WL, Stephenson I, Gibbs EP, Chen L, Smith C, Hill RC, Ferro P, Pompey J, Bright RA, Medina MJ, Johnson CM, Olsen CW, Cox NJ, Klimov AI, Katz JM, Donis RO. Transmission of equine influenza virus to dogs.. Science 2005 Oct 21;310(5747):482-5.
        pubmed: 16186182doi: 10.1126/science.1117950google scholar: lookup
      27. Tu J, Zhou H, Jiang T, Li C, Zhang A, Guo X, Zou W, Chen H, Jin M. Isolation and molecular characterization of equine H3N8 influenza viruses from pigs in China.. Arch Virol 2009;154(5):887-90.
        pubmed: 19396578doi: 10.1007/s00705-009-0381-1google scholar: lookup
      28. Mumford J. Progress in the control of equine influenza. Proc. 6th Int. Conference on Equine Infectious Diseases Cambridge, 1992; 207–218.
      29. Mumford JA. Vaccines and viral antigenic diversity.. Rev Sci Tech 2007 Apr;26(1):69-90.
        pubmed: 17633294
      30. Mumford J, Wood J. WHO/OIE meeting: consultation on newly emerging strains of equine influenza. 18-19 May 1992, Animal Health Trust, Newmarket, Suffolk, UK.. Vaccine 1993;11(11):1172-5.
        pubmed: 8249440doi: 10.1016/0264-410x(93)90092-cgoogle scholar: lookup
      31. Kawaoka Y, Bean WJ, Webster RG. Evolution of the hemagglutinin of equine H3 influenza viruses.. Virology 1989 Apr;169(2):283-92.
        pubmed: 2705299doi: 10.1016/0042-6822(89)90153-0google scholar: lookup
      32. Daly JM, Lai AC, Binns MM, Chambers TM, Barrandeguy M, Mumford JA. Antigenic and genetic evolution of equine H3N8 influenza A viruses.. J Gen Virol 1996 Apr;77 ( Pt 4):661-71.
        pubmed: 8627254doi: 10.1099/0022-1317-77-4-661google scholar: lookup
      33. OIE. Conclusions and recommendation form the consultation meeting of OIE and WHO experts on equine influenza, Newmarket, United Kingdom, September 18–19, 1995. OIE Bull 1996; 108:482–484.
      34. Lai AC, Chambers TM, Holland RE Jr, Morley PS, Haines DM, Townsend HG, Barrandeguy M. Diverged evolution of recent equine-2 influenza (H3N8) viruses in the Western Hemisphere.. Arch Virol 2001;146(6):1063-74.
        pubmed: 11504416doi: 10.1007/s007050170106google scholar: lookup
      35. Expert surveillance panel on equine influenza vaccine composition, National Institute for Medical Research, Mill Hill, London (United Kingdom). Conclusions and recommendation. OIE Bull 2009; 2: 42–43.
      36. Bryant NA, Rash AS, Russell CA, Ross J, Cooke A, Bowman S, MacRae S, Lewis NS, Paillot R, Zanoni R, Meier H, Griffiths LA, Daly JM, Tiwari A, Chambers TM, Newton JR, Elton DM. Antigenic and genetic variations in European and North American equine influenza virus strains (H3N8) isolated from 2006 to 2007.. Vet Microbiol 2009 Jul 2;138(1-2):41-52.
        pubmed: 19346084doi: 10.1016/j.vetmic.2009.03.004google scholar: lookup
      37. Quinlivan M, Dempsey E, Ryan F, Arkins S, Cullinane A. Real-time reverse transcription PCR for detection and quantitative analysis of equine influenza virus.. J Clin Microbiol 2005 Oct;43(10):5055-7.

      Citations

      This article has been cited 29 times.
      1. Chappell DE, Barnett DC, James K, Craig B, Bain F, Gaughan E, Schneider C, Vaala W, Barnum SM, Pusterla N. Voluntary Surveillance Program for Equine Influenza Virus in the United States during 2008-2021.. Pathogens 2023 Jan 27;12(2).
        doi: 10.3390/pathogens12020192pubmed: 36839464google scholar: lookup
      2. Burashev Y, Orynbayev M, Zakarya K, Abduraimov Y, Kassenov M, Strochkov V, Kozhabergenov N, Usserbayev B, Melisbek A, Shirinbekov M, Sypatay N, Sultankulova K. Complete Coding Genome Sequence of an Influenza A/H3N8 Equine Virus Isolated in Kazakhstan in 2007.. Microbiol Resour Announc 2022 Oct 20;11(10):e0114721.
        doi: 10.1128/mra.01147-21pubmed: 36094178google scholar: lookup
      3. Whitlock F, Grewar J, Newton R. An epidemiological overview of the equine influenza epidemic in Great Britain during 2019.. Equine Vet J 2023 Jan;55(1):153-164.
        doi: 10.1111/evj.13874pubmed: 36054725google scholar: lookup
      4. Whitlock F, Murcia PR, Newton JR. A Review on Equine Influenza from a Human Influenza Perspective.. Viruses 2022 Jun 15;14(6).
        doi: 10.3390/v14061312pubmed: 35746783google scholar: lookup
      5. Knox A, Beddoe T. Isothermal Nucleic Acid Amplification Technologies for the Detection of Equine Viral Pathogens.. Animals (Basel) 2021 Jul 20;11(7).
        doi: 10.3390/ani11072150pubmed: 34359278google scholar: lookup
      6. Olguin-Perglione C, Barrandeguy ME. An Overview of Equine Influenza in South America.. Viruses 2021 May 12;13(5).
        doi: 10.3390/v13050888pubmed: 34065839google scholar: lookup
      7. Allkofer A, Garvey M, Ryan E, Lyons R, Ryan M, Lukaseviciute G, Walsh C, Venner M, Cullinane A. Primary vaccination in foals: a comparison of the serological response to equine influenza and equine herpesvirus vaccines administered concurrently or 2 weeks apart.. Arch Virol 2021 Feb;166(2):571-579.
        doi: 10.1007/s00705-020-04846-6pubmed: 33410993google scholar: lookup
      8. Reemers S, Sonnemans D, Horspool L, van Bommel S, Cao Q, van de Zande S. Determining Equine Influenza Virus Vaccine Efficacy-The Specific Contribution of Strain Versus Other Vaccine Attributes.. Vaccines (Basel) 2020 Sep 3;8(3).
        doi: 10.3390/vaccines8030501pubmed: 32899189google scholar: lookup
      9. Blanco-Lobo P, Rodriguez L, Reedy S, Oladunni FS, Nogales A, Murcia PR, Chambers TM, Martinez-Sobrido L. A Bivalent Live-Attenuated Vaccine for the Prevention of Equine Influenza Virus.. Viruses 2019 Oct 11;11(10).
        doi: 10.3390/v11100933pubmed: 31614538google scholar: lookup
      10. Gahan J, Garvey M, Asmah Abd Samad R, Cullinane A. Whole Genome Sequencing of the First H3N8 Equine Influenza Virus Identified in Malaysia.. Pathogens 2019 May 10;8(2).
        doi: 10.3390/pathogens8020062pubmed: 31083430google scholar: lookup
      11. Milwid RM, O'Sullivan TL, Poljak Z, Laskowski M, Greer AL. Comparing the effects of non-homogenous mixing patterns on epidemiological outcomes in equine populations: A mathematical modelling study.. Sci Rep 2019 Mar 1;9(1):3227.
        doi: 10.1038/s41598-019-40151-2pubmed: 30824806google scholar: lookup
      12. Martínez-Sobrido L, Peersen O, Nogales A. Temperature Sensitive Mutations in Influenza A Viral Ribonucleoprotein Complex Responsible for the Attenuation of the Live Attenuated Influenza Vaccine.. Viruses 2018 Oct 15;10(10).
        doi: 10.3390/v10100560pubmed: 30326610google scholar: lookup
      13. Singh RK, Dhama K, Karthik K, Khandia R, Munjal A, Khurana SK, Chakraborty S, Malik YS, Virmani N, Singh R, Tripathi BN, Munir M, van der Kolk JH. A Comprehensive Review on Equine Influenza Virus: Etiology, Epidemiology, Pathobiology, Advances in Developing Diagnostics, Vaccines, and Control Strategies.. Front Microbiol 2018;9:1941.
        doi: 10.3389/fmicb.2018.01941pubmed: 30237788google scholar: lookup
      14. Burashev Y, Strochkov V, Sultankulova K, Orynbayev M, Sansyzbay A, Sandybayev N, Nurabayev S, Savitskaya I, Rock DL, Tulman ER. Complete Genome Sequencing of Two Equine Influenza A(H3N8) Virus Strains Isolated in Kazakhstan.. Genome Announc 2018 Jun 28;6(26).
        doi: 10.1128/genomeA.00574-18pubmed: 29954896google scholar: lookup
      15. Spence KL, O'Sullivan TL, Poljak Z, Greer AL. Using a computer simulation model to examine the impact of biosecurity measures during a facility-level outbreak of equine influenza.. Can J Vet Res 2018 Apr;82(2):89-96.
        pubmed: 29755187
      16. Gildea S, Garvey M, Lyons P, Lyons R, Gahan J, Walsh C, Cullinane A. Multifocal Equine Influenza Outbreak with Vaccination Breakdown in Thoroughbred Racehorses.. Pathogens 2018 Apr 17;7(2).
        doi: 10.3390/pathogens7020043pubmed: 29673169google scholar: lookup
      17. Nemoto M, Yamanaka T, Bannai H, Tsujimura K, Kokado H. Complete Genomic Sequences of H3N8 Equine Influenza Virus Strains Used as Vaccine Strains in Japan.. Genome Announc 2018 Mar 22;6(12).
        doi: 10.1128/genomeA.00172-18pubmed: 29567739google scholar: lookup
      18. Rodriguez L, Reedy S, Nogales A, Murcia PR, Chambers TM, Martinez-Sobrido L. Development of a novel equine influenza virus live-attenuated vaccine.. Virology 2018 Mar;516:76-85.
        doi: 10.1016/j.virol.2018.01.005pubmed: 29331866google scholar: lookup
      19. Yamanaka T, Nemoto M, Bannai H, Tsujimura K, Matsumura T, Kokado H, Gildea S, Cullinane A. Neutralization antibody response to booster/priming immunization with new equine influenza vaccine in Japan.. J Vet Med Sci 2018 Mar 2;80(2):382-386.
        doi: 10.1292/jvms.17-0538pubmed: 29237998google scholar: lookup
      20. Rash A, Morton R, Woodward A, Maes O, McCauley J, Bryant N, Elton D. Evolution and Divergence of H3N8 Equine Influenza Viruses Circulating in the United Kingdom from 2013 to 2015.. Pathogens 2017 Feb 8;6(1).
        doi: 10.3390/pathogens6010006pubmed: 28208721google scholar: lookup
      21. Gamoh K, Nakamura S. Update of inactivated equine influenza vaccine strain in Japan.. J Vet Med Sci 2017 Mar 23;79(3):649-653.
        doi: 10.1292/jvms.16-0558pubmed: 28163276google scholar: lookup
      22. Olguin Perglione C, Golemba MD, Torres C, Barrandeguy M. Molecular Epidemiology and Spatio-Temporal Dynamics of the H3N8 Equine Influenza Virus in South America.. Pathogens 2016 Oct 16;5(4).
        doi: 10.3390/pathogens5040061pubmed: 27754468google scholar: lookup
      23. Yamanaka T, Nemoto M, Bannai H, Tsujimura K, Kondo T, Matsumura T, Gildea S, Cullinane A. Assessment of antigenic difference of equine influenza virus strains by challenge study in horses.. Influenza Other Respir Viruses 2016 Nov;10(6):536-539.
        doi: 10.1111/irv.12418pubmed: 27465864google scholar: lookup
      24. Joseph U, Su YC, Vijaykrishna D, Smith GJ. The ecology and adaptive evolution of influenza A interspecies transmission.. Influenza Other Respir Viruses 2017 Jan;11(1):74-84.
        doi: 10.1111/irv.12412pubmed: 27426214google scholar: lookup
      25. Perglione CO, Gildea S, Rimondi A, Miño S, Vissani A, Carossino M, Cullinane A, Barrandeguy M. Epidemiological and virological findings during multiple outbreaks of equine influenza in South America in 2012.. Influenza Other Respir Viruses 2016 Jan;10(1):37-46.
        doi: 10.1111/irv.12349pubmed: 26406274google scholar: lookup
      26. Paillot R. A Systematic Review of Recent Advances in Equine Influenza Vaccination.. Vaccines (Basel) 2014 Nov 14;2(4):797-831.
        doi: 10.3390/vaccines2040797pubmed: 26344892google scholar: lookup
      27. Kim EJ, Kim BH, Yang S, Choi EJ, Shin YJ, Song JY, Shin YK. Antibody responses after vaccination against equine influenza in the Republic of Korea in 2013.. J Vet Med Sci 2015 Nov;77(11):1517-21.
        doi: 10.1292/jvms.15-0192pubmed: 26062436google scholar: lookup
      28. Pouwels HG, Van de Zande SM, Horspool LJ, Hoeijmakers MJ. Efficacy of a non-updated, Matrix-C-based equine influenza subunit-tetanus vaccine following Florida sublineage clade 2 challenge.. Vet Rec 2014 Jun 21;174(25):633.
        doi: 10.1136/vr.101993pubmed: 24795071google scholar: lookup
      29. Ault A, Zajac AM, Kong WP, Gorres JP, Royals M, Wei CJ, Bao S, Yang ZY, Reedy SE, Sturgill TL, Page AE, Donofrio-Newman J, Adams AA, Balasuriya UB, Horohov DW, Chambers TM, Nabel GJ, Rao SS. Immunogenicity and clinical protection against equine influenza by DNA vaccination of ponies.. Vaccine 2012 Jun 6;30(26):3965-74.
        doi: 10.1016/j.vaccine.2012.03.026pubmed: 22449425google scholar: lookup